United Kingdom· GB-APID-10354711000001109
Thymoglobuline 25mg powder and solvent for solution for infusion vials
A antithymocyte immunoglobulin (rabbit) product containing antithymocyte immunoglobulin (rabbit), registered in United Kingdom by Sanofi. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Antithymocyte immunoglobulin (rabbit) is registered in 11 of 19 countries.
Countries holding a registration under ATC L04AA04 (antithymocyte immunoglobulin (rabbit)), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Antithymocyte immunoglobulin (rabbit) · ATC L04AA04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Antithymocyte immunoglobulin (rabbit)
- Manufacturer
- Sanofi
- Country
- United Kingdom (GB)
- ATC code
- L04AA04
- ATC class
- Antithymocyte immunoglobulin (rabbit)
- Defined daily dose
- 0.1 g, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5030045000111
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Antithymocyte immunoglobulin (rabbit) in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandThymoglobuline 25 mg powder for solution for infusionSanofi B.V.
- SwitzerlandGrafalon
- CzechiaGRAFALONNeovii Biotech GmbH, Gräfelfing
- SpainGRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSIONNeovii Biotech Gmbh
- United StatesThymoglobulinGenzyme Corporation
- CanadaTHYMOGLOBULINSANOFI-AVENTIS CANADA INC
- NetherlandsGrafalon 20 mg/ml concentraat voor oplossing voor infusieNeovii Biotech GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/de9a8857-cc46-43b8-9400-898163de9805 GET /v1/drugs/de9a8857-cc46-43b8-9400-898163de9805?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "10354711000001109",
"desc": "Thymoglobuline 25mg powder and solvent for solution for infusion vials (Sanofi)",
"form": "Powder and solvent for solution for infusion",
"vpid": "10354511000001104",
"source": "dmd",
"vtm_id": "777387005",
"strength": "25 mg",
"substance": "Antithymocyte immunoglobulin (rabbit)",
"ingredient": "Antithymocyte immunoglobulin (rabbit)",
"supplier_code": "9190711000001101"
}See everything about antithymocyte immunoglobulin (rabbit).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.